Published: Jan. 1, 2024
Language: Английский
BMJ Public Health, Journal Year: 2025, Volume and Issue: 3(1), P. e001801 - e001801
Published: Feb. 1, 2025
Introduction Symptoms from post COVID-19 condition (PCC) can impair functioning in working-age adults. However, there is uncertainty about the relationship between PCC and work outcomes. This study aimed to assess health-related adverse outcomes individuals with a history compared others who had COVID-19. Methods was cross-sectional which participants British Columbia (BC) completed an online questionnaire. Participants comprised adults tested positive for SARS-CoV-2 by PCR at least 2 years before questionnaire completion were working age (18–64) time of infection. status determined self-report. The evaluated included change occupation or employer, reduced workload, increased sick days COVID-19, early retirement indefinite leave. Analyses weighted reflect characteristics BC. Propensity score overlap weighting used adjust relevant sociodemographic clinical covariates. Results Among 1106 participants, 966 (87.3%) employed when they contracted analyses. Of these 47.8% female, median 37 46.9% history. Compared other those more likely have outcome (46.5% vs 24.9%; adjusted OR (aOR) 2.6 (95% CI 1.7 4.0)) reported greater number first since contracting (adjusted mean difference 43 20 65)). risk especially high post-COVID-19 fatigue (aOR 4.6 2.7 7.9)), fever 4.0 9.6)), weakness 3.8 2.2 6.3)), palpitations 3.3 2.0 5.0)) brain fog 3.2 5.0)). Conclusions associated important consideration clinicians, employers health system leaders.
Language: Английский
Citations
1
The American Journal of Medicine, Journal Year: 2024, Volume and Issue: unknown
Published: May 1, 2024
Background Most working-age (18-64) adults have been infected with SARS-CoV-2, and some may developed post-COVID-19 condition (PCC). However, health-related quality of life (HRQOL) greater than 2 years following infection remains uncharacterized. Methods In this cross-sectional study, COVID-19 survivors from throughout British Columbia (BC), Canada, completed a questionnaire post-infection. PCC status was self-reported, HRQOL assessed using the EuroQol 5-dimension 5-level (EQ-5D-5L) instrument. We compared in those current PCC, recovered without history PCC. Iterative proportional fitting used to weight analyses be representative BC. Multivariable regression models were adjust for confounders. Results Of 1,135 analyzed participants, 19.2% had 27.6% Compared participants similar weighted mean EQ-5D health utility (adjusted difference -0.02 [95%CI -0.03, 0.00]), but lower -0.08 -0.12, -0.05]). more likely report problems mobility odds ratio (aOR) 6.00 2.88-12.52]), self-care (aOR 5.96 1.84-19.32]), usual activities 8.00 4.27-14.99]), pain/discomfort 4.28 2.46-7.48]), anxiety/depression 3.45 1.90-6.27]). Conclusions who survived COVID-19, is high among never or individuals ongoing symptoms are deficits multiple functional domains. These findings underscore importance implementing targeted healthcare interventions improve long-term
Language: Английский
Citations
3
JMIR Public Health and Surveillance, Journal Year: 2024, Volume and Issue: 10, P. e45513 - e45513
Published: June 6, 2024
SARS-CoV-2 variants of concern (VOCs) emerged and rapidly replaced the original strain worldwide. The increased transmissibility these new led to increases in infections, hospitalizations, mortality. However, there is a scarcity retrospective investigations examining severity all main VOCs presence key public health measures within various social determinants (SDOHs).
Language: Английский
Citations
1
The American Journal of Medicine, Journal Year: 2024, Volume and Issue: unknown
Published: April 1, 2024
Language: Английский
Citations
1
International Journal of Infectious Diseases, Journal Year: 2024, Volume and Issue: 150, P. 107287 - 107287
Published: Nov. 1, 2024
Objectives: We evaluated all-cause healthcare utilization among those with vaccine-associated myocarditis, compared to vaccinees without post-vaccination myocarditis.Methods: conducted a retrospective cohort study in individuals aged 12 and older who received COVID-19 mRNA vaccination British Columbia. Exposure was defined as an ED visit or hospitalization for myocarditis within 21 days post-vaccination. The primary outcome utilization. Ratios of rate ratios (RRRs) exposure-associated were calculated using difference-in-differences (DiD) analysis.Results: In the post-index period, exposed unexposed groups showed substantial difference (RD = 15.30 [95% CI, 14.47-16.13). A 51% overall increase observed over 18 months (RRR, 1.51 [95%CI, 1.08-2.11]). initial six months, surpassed 18-month estimate, exhibiting 125% 2.25 1.43-3.52]), while last no statistically significant change 1.03 0.72-1.47]). An additional 9.1 (95%CI, 8.53-9.71) visits per person attributed (total excess 938.26 visits).Conclusion: surge post-exposure, mainly outpatient follow-ups, followed by return baseline rates, indicates positive prognosis supports vaccine's safety profile.
Language: Английский
Citations
0
Published: Jan. 1, 2024
Language: Английский
Citations
0